Read More 4 minute read Business Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities SALT LAKE CITY and TORONTO and MONTRÉAL — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology… bySarjatha KpMay 10, 2023